Cargando…
Generation of an anti-angiogenic endothelial progenitor cell line via endostatin gene transfer
The viability of endothelial progenitor cells (EPCs) as a therapeutic treatment for neovascularization (NV) was subject to investigation in the present study. Furthermore, endostatin has previously been demonstrated to be an inhibitor of angiogenesis and a suppressant of vascular leakage. The aim of...
Autores principales: | Ai, Jing, Sun, Jun-Hui, Wan, Ting, Ma, Jian, Feng, Lei, Yao, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866025/ https://www.ncbi.nlm.nih.gov/pubmed/29484399 http://dx.doi.org/10.3892/mmr.2018.8623 |
Ejemplares similares
-
Effects of lentivirus-mediated endostatin on endothelial progenitor cells
por: Ai, Jing, et al.
Publicado: (2017) -
Endostatin and anastellin inhibit distinct aspects of the angiogenic process
por: Neskey, David M, et al.
Publicado: (2008) -
Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas
por: Zhang, Yue-Lin, et al.
Publicado: (2020) -
Anti-Angiogenic Effects of a Mutant Endostatin: A New Prospect for Treating Retinal and Choroidal Neovascularization
por: Bai, Yujing, et al.
Publicado: (2014) -
Deciphering the anti-angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer
por: Lv, Jin-Yan, et al.
Publicado: (2016)